ArticleFrontiers in medicine2026
The road from standardized to personalized medicine: the difficult-to-treat framework as a critical waystation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Standardized care has become the cornerstone of modern medicine. However, many patients remain symptomatic despite following the appropriate guidelines and the application of treatment escalation, and become difficult-to-treat (D2T). The D2T concept can also provide a framework for identifying when standard care is no longer sufficient and when individualized management becomes clinically justified. Rather than reflecting therapeutic failure alone, the D2T state can be a consequence of various reasons, including underlying biological, clinical, psychosocial, or contextual complexity, which draws attention to the importance of multidomain reassessment in these conditions. Combined with emerging artificial intelligence-based trajectory recognition, the D2T framework may support earlier identification of complex patients and more selective implementation of precision strategies. In this way, the D2T concept can be understood as a practical bridge between standardized medicine and individualized care, with a potential relevance as a cross-disciplinary framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.